✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous

Johnson Pharmacare Ltd.

JOHNPHARMA

Market Cap
₹53 Cr.
P/E
0.00

Johnson Pharmacare Ltd.

  • Johnson Pharmacare
  • Euro Asia Exports
  • IFL Enterprises
FAQs on Johnson Pharmacare Ltd. Shareprice

Johnson Pharmacare has given lower returns compared to its competitors.
Johnson Pharmacare has grown at ~10.08% over the last 8yrs while peers have grown at a median rate of 36.31%

Johnson Pharmacare is not expensive.
Latest PE of Johnson Pharmacare is 0.0, while 3 year average PE is 91.39.
Also latest EV/EBITDA of Johnson Pharmacare is 0.0 while 3yr average is 290.

View FAQ's On Business
Growth Table
  • Johnson Pharmacare Ltd.
  • Euro Asia Exports
  • IFL Enterprises
Balance Sheet
  • Johnson Pharmacare Ltd.
  • Euro Asia Exports
  • IFL Enterprises
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Johnson Pharmacare Ltd.
  • Euro Asia Exports
  • IFL Enterprises
Cash Flow
  • Johnson Pharmacare Ltd.
  • Euro Asia Exports
  • IFL Enterprises
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Johnson Pharmacare Ltd.
  • Euro Asia Exports
  • IFL Enterprises
Quarterly Results
  • Johnson Pharmacare Ltd.
  • Euro Asia Exports
  • IFL Enterprises
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Johnson Pharmacare Ltd. Financials

Johnson Pharmacare balance sheet is weak and might have solvency issues

Yes, The debt of Johnson Pharmacare is increasing.
Latest debt of Johnson Pharmacare is ₹1.99 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹1.95 Crs.

The profit is oscillating.
The profit of Johnson Pharmacare is -₹0.2 Crs for Mar 2024, -₹1.29 Crs for Mar 2023 and ₹0.1 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Johnson Pharmacare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

NA

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech